The National Societyfor HistotechnologyThe National Societyfor Histotechnology

Earn CEU’s - One contact hour per attendee per session

Group Learning - Unlimited number of participants for one low fee

Archive Sessions - Archived materials are available for 2 years to train new staff

presents the

2017Webinar Series

for Labs

Affordable Education - Order the 12 month series for only$1595 by January 24, 2017. A savings of over $200.00!

Registration Fees: $150.00 per Session and includes all materials, login instructions, archived recordings, and contact hours. Please note you may not use the purchased login information at multiple locations of your organization. Only one site may use the login for the live event. If you

have additional sites interested in a webinar, they must register.

2017 Webinar Registration Information

2017 Webinar Registration Form

How Does it Work?NSH webinars are a great, inexpensive way to provide continuing education to a large number of employees. The cost for each session is the same regardless of the number of attendees. The one hour session is usually held the fourth Wednesday of the month, beginning at 1:00 PM Eastern Standard Time. Occasionally, due to holidays, it may be the third Wednesday of the month.

What Do I Need to Participate?To participate you will need a computer with speakers or a telephone for the audio portion and a computer with an internet connection to view the presentation.

Do These Sessions Qualify for Contact Hours?Attendees receive one (1) contact hour for participation in a session. An archived version of the session is also provided to each participating lab about 1 week following the live event. Individuals unable to participate on the day of the session may review the material, and earn one contact hour. This method of earning contact hours is valid for two years from the original date of the session.

Step 1: Site Coordinator Contact Information

Site Coordinator: ___________________________________ Organization: _________________________________________________

Street: _________________________________________________________________________________________________________

City: _______________________________ State: ________ Postal Code: _____________ Country: ______________________________

Phone: ____________________________________________________ Email: ________________________________________________

Step 2: Select Your Sessions

____ Complete Series ($1595, by 1/24/17)

____ 1/25/17 ($150) ____ 7/26/17 ($150)

____ 2/22/17 ($150) ____ 8/23/17 ($150)

____ 3/22/17 ($150) ____ 9/27/17 ($150)

____ 4/26/17 ($150) ____ 10/25/17 ($150)

____ 5/24/17 ($150) ____ 11/29/17 ($150)

____ 6/28/17 ($150) ____ 12/20/17 ($150)

Step 4: Payment Information

____ A check for the full amount made out to NSH is included with this form

____ A fully executed Purchase Order is included. P.O. # _____________

____ Please charge my credit card the total amount due. (DISC, MC, Visa, AMX)

CC Holder Name: _______________________________________________

CC Holder Email: _______________________________________________

CC #: _________________________________________________________

Expiration Date: ______________________ CVV Code: ________________

Tax ID #: 52-111-1284

Step 3: NSH Memberships for Staff

____ No thanks

____ Add ______ x $80 for My Staff(# of memberships) - Attached list of names & their emails required

Option 1: Fax this form to 443-535-4055 Option 2: Mail to NSH, 8850 Stanford Blvd. Suite 2900, Columbia, MD 21045Option 3: Register on-line at www.nsh.org

Source Code: WEBDL17

MAy 24 – PD-L1 Testing and ImmunotherapyDr. Charles Koyias, Roche Diagnostics, Indianapolis, INThe presentation provides an overview of the relevance of PD-L1 as a cancer biomarker, the difference between the FDA classification of Complementary vs Companion Diagnostics, Targeted Therapy vs. Immunotherapy, current FDA approved PD-L1 IHC assays and indications for use & scoring, current FDA approved anti-PD1/anti-PD-L1 immunotherapies, and immunotherapy clinical trial data.

JuNe 28 – A Minimally Invasive Method (Liquid Biopsy) Enabling Detection of Circulating Cells Using Cell Enrichment and Advanced StainingDouglas yamanishi, PhD, Sakura Finetek, Torrance, CAThis webinar will present an overview for utilizing whole blood as a “liquid biopsy”. Liquid biopsies may provide a means of monitoring the status of a cellular or tissue-based event (e.g. cancer or pregnancy) using a minimally invasive needle stick for specimen acquisition. The feasibility of using different cell enrichment (positive and negative) and cell identification (advanced staining) technologies will be presented.

JuLy 26 – Frozen SectioningMelinda M. Chow, MS, HT(ASCP), Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ Frozen sectioning is a quick procedure generally performed in a Mohs histopathology laboratory for a quick diagnosis while patients are waiting for the results. This webinar will cover the uses of frozen sections, different methods of freezing specimens, the art of cryosectioning and rapid hematoxylin and eosin staining of the frozen sections. The causes of the problems encountered and how to troubleshoot them each step of the way will also be discussed.

AuguST 23 – Implementation of a Digital Pathology Solutionelizabeth A. Chlipala, BS, HTL(ASCP) QIHC, Premier Laboratory, LLC, Longmont, COThis webinar will cover how standardization and overall quality of histology preparations are important to the successfulness in implementation of a digital pathology solution. There will be discussion on how to set up workflow, standard operating procedures, internal training and competency, and verification/validation of the scanning process. In addition, the last portion of the webinar will discuss histology use cases.

SePTeMBeR 27 – How to Prepare for a CAP InspectionJacqueline Brooks, MB, SCT, HTL (ASCP), Cunningham Pathology, Birmingham, ALTo fully understand how to prepare for a CAP inspection or any of the other Laboratory Regulatory inspections you must understand how the system works. This webinar will discuss the roles of CLIA, CAP, TJC and CMS. We will discuss the CAP application process for inspection and its timelines. We will spend considerable time on the CAP Checklists. We will review the changes made in 2016 and the presenter will share her experiences meeting the standards with emphasis on AP.

OCTOBeR 25 – Connective Tissue Staining Debra Wood, MS.ed., HT(ASCP), Indiana university School of Medicine, Indianapolis, INThis presentation will provide the basics of connective tissue stains as well as some not so common uses. We will look at images scanned on the Aperio and provided information on tools that can be used that are free or less expensive.

NOveMBeR 29 – Principles of Emergency Management for Your OrganizationAngela McNabola, MS, HT(ASCP) SLS, QIHC, Bridgeport Hospital, Bridgeport, CTThere are many things to consider when preparing your organization for an emergency event, whether it is chemical spill, a man made event or natural disaster. The goal is to have a well rehearsed action plan before it happens. This webinar will discuss what CBRNe events are, how to perform a hazard risk assessment and discuss what resources and procedures are needed to be prepared.

DeCeMBeR 20 – Basic Troubleshooting Skills for the IHC Tech Christina Hopkins, BS/MLS(ASCP), Ohio State university Wexner Medical Center, Columbus, OHThis teleconference will open with a quick overview of the immunohistochemistry process, but will primarily discuss basic troubleshooting in the clinical IHC laboratory. The troubleshooting of manual protocols will be reviewed, as well as troubleshooting automation across multiple platforms.

2017 NSHWebinar SeriesFor Labs

JANuARy 25 – Evolution of Predictive Diagnostics: From Companion to Complementary and Immunohistochemistry to Next Generation SequencingPresented by Julie Jay, PhD, International Product Manager, Companion Diagnostics, ventana Medical Systems, Inc., Tucson, AZThis webinar will present an overview of the evolution of predictive diagnostics from the perspective of the regulatory terminology, the technology platforms and the utilization of biomarkers to aid in patient treatment decisions. Predictive diagnostics include companion diagnostics that select patients eligible for treatment as well as complementary diagnostics which provide information about how well a patient may respond to the therapy. Predictive diagnostics have utilized IHC, ISH as well as PCR, and NgS predictive diagnostics assays are currently under development. Due the fact that protein and gene targets inform drug development to enable clinical success, predictive diagnostics will play an increasing role in patient care.

FeBRuARy 22 – Managing Toxic and Disruptive BehaviorsLisbeth A. O’Malley, BA, education, university of Michigan, Ann Arbor, MIIn this webinar we will explore the toxic behaviors found in the workplace. We will not only identify the disruptor, but those around them that also add to the situation. We will discuss the impact on the individuals, the team and the organization, and learn of some techniques to minimize this. We will close with strategies to alleviate the symptoms of being a “Toxic Handler”

MARCH 22 – The Role of Kidney Biopsy in the Diagnosis of Kidney Disease Pamela gibson, MD, university of vermont Medical Center/university of vermont College of Medicine, Burlington, vTKidney biopsies can provide a wealth of information related to the diagnosis of kidney disease and the prognosis for the patient’s kidney function. Kidney biopsies however are not needed in all forms of kidney disease and are not without morbidity to the patient. This seminar will review the basic approach to the work up of kidney disease from the clinical perspective and introduce the audience to the reasons why a biopsy might be performed using real patient cases. The cases will help emphasize the role of special stains and immunofluorescence in the assessment of the kidney biopsy and will also address the importance of electron microscopy in the comprehensive diagnosis of kidney diseases.

APRIL 26 – The Basics are Critical: Tissue Fixation, Pre-analytical Variability, and BiomarkersJennifer Freeland, BS, HTL (ASCP), ThermoFisher Scientific, Kalamazoo, MITissue fixation is one of the very first chapters in all the histology text books for a very good reason: it is critical to specimen quality. With the emergence of clinically relevant biomarkers, there is the renewed focus on standardization of fixation and other pre-analytical variables: fixation has again become a central topic. This webinar will explore fixation in a historical sense, explore fixative types and chemistries, and compare results of poorly fixed tissues with well-fixed tissues. We will also consider the impact of fixation and other affiliated pre-analytical variables on modern biomarkers of clinical interest.